23:52 , Aug 8, 2019 |  BC Innovations  |  Tools & Techniques

Checkpoint inhibitors are bringing oncolytic viruses back into the spotlight

Early clinical readouts for next-generation oncolytic viruses are hinting at high efficacy when combined with checkpoint inhibitors, and pharmas are off to the races to find the best pairings. After more than two decades of...
18:52 , Jul 12, 2018 |  BC Innovations  |  Product R&D

All-in-one viruses

Having taken its lead oncolytic virus into the clinic, PsiOxus Therapeutics Ltd. is building an immuno-oncology platform that uses engineered versions of the vector to selectively target multiple genes at a time to tumor cells...
03:02 , Jun 30, 2018 |  BioCentury  |  Finance

Smitten by SMID-caps

Risk is pervasive heading into the third quarter and choppy waters are expected, but 13 buysiders told BioCentury they’re not afraid to stay the course. A politically charged environment is likely to intensify as the...
18:58 , May 4, 2018 |  BC Week In Review  |  Company News

Janssen grabs up oncolytic virus company BeneVir

The Janssen Pharmaceuticals Inc. unit of Johnson & Johnson (NYSE:JNJ) is acquiring oncolytic virus company BeneVir Biopharm Inc. (Rockville, Md.). BeneVir shareholders will receive $140 million up front and are eligible for $900 million in...
16:09 , May 2, 2018 |  BC Extra  |  Company News

Janssen to acquire oncolytic virus company BeneVir

The Janssen Pharmaceuticals Inc. unit of Johnson & Johnson (NYSE:JNJ) is acquiring oncolytic virus company BeneVir Biopharm Inc. (Rockville, Md.). BeneVir shareholders will receive $140 million up front and are eligible for $900 million in...
08:00 , Feb 29, 2016 |  BC Week In Review  |  Financial News

BeneVir financial update

BeneVir Biopharm Inc. , Rockville, Md.   Business: Cancer   Date announced: 2016-02-16   Note: BeneVir raised an additional $1 million in a series A round, bringing the total raised to $3 million, according to...
08:00 , Nov 24, 2014 |  BC Week In Review  |  Financial News

BeneVir completes venture financing

BeneVir Biopharm Inc. , Rockville, Md.   Business: Cancer   Date completed: 2014-11-19   Type: Venture financing   Raised: Not disclosed   Investor: HC2 Holdings   Note: The amount raised is not disclosed.  ...